Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology;Surface enhanced laser desorption/ionization (SELDI): tecnología proteómica y su aplicación en oncología

Medicina Clinica

Volumn 131, Issue 8, 2008, Pages 312-317

  Espejel, Fulgencio ^a   Carlos Roa, Juan ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

Author keywords

Biomarker; Cancer; Proteomic

Indexed keywords

CANCER DIAGNOSIS; CANCER RESEARCH; FEMALE GENITAL TRACT TUMOR; GASTROINTESTINAL TUMOR; HUMAN; LUNG CANCER; ONCOLOGY; PROGNOSIS; PROSTATE CANCER; PROTEOMICS; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; LUNG TUMOR; MALE; MASS SPECTROMETRY; NEOPLASM; PROSTATE TUMOR;

TUMOR MARKER;

BREAST NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; GENITAL NEOPLASMS, FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL ONCOLOGY; NEOPLASMS; PROSTATIC NEOPLASMS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 58149117672     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13125789     Document Type: Review

References (50)

1. Honore B., Ostergaard M., and Vorum H. Functional genomics studied by proteomics. Bioessays 26 (2004) 901-915
2. Krishna R.G., and Wold F. Post-translational modification of proteins. Adv Enzymol Relat Areas Mol Biol 67 (1993) 265-298
3. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431 (2004) 931-945
4. Srinivas P.R., Kramer B.S., and Srivastava S. Trends in biomarker research for cancer detection. Lancet Oncol 2 (2001) 698-704
5. Guo Y., Fu Z., and Van Eyk J.E. A proteomic primer for the clinician. Proc Am Thorac Soc 4 (2007) 9-17
6. Sellers T.A., and Yates J.R. Review of proteomics with applications to genetic epidemiology. Genet Epidemiol 24 (2003) 83-98
7. Lewis T.S., Hunt J.B., Aveline L.D., Jonscher K.R., Louie D.F., Yeh J.M., et al. Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry. Mol Cell 6 (2000) 1343-1354
8. Gorg A., Obermaier C., Boguth G., Harder A., Scheibe B., Wildgruber R., et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21 (2000) 1037-1053
9. Corthals G.L., Wasinger V.C., Hochstrasser D.F., and Sánchez J.C. The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 21 (2000) 1104-1115
10. Wall D.B., Kachman M.T., Gong S., Hinderer R., Parus S., Misek D.E., et al. Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry. Anal Chem 72 (2000) 1099-1111
11. Delahunty C., and Yates III J.R. Protein identification using 2D-LC-MS/MS. Methods 35 (2005) 248-255
12. MacCoss M.J., and Matthews D.E. Quantitative MS for proteomics: teaching a new dog old tricks. Anal Chem 77 (2005) 294A-302A
13. Yao X., Freas A., Ramírez J., Demirev P.A., and Fenselau C. Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal Chem 73 (2001) 2836-2842
14. He Q.Y., and Chiu J.F. Proteomics in biomarker discovery and drug development. J Cell Biochem 89 (2003) 868-886
15. Merchant M., and Weinberger S.R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21 (2000) 1164-1177
16. Cho W.C. Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 6 (2007) 25
17. Seibert V., Ebert M.P., and Buschmann T. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery. Brief Funct Genomic Proteomic 4 (2005) 16-26
18. Jain K.K. Role of oncoproteomics in the personalized management of cancer. Expert Rev Proteomics 1 (2004) 49-55
19. Lopez J.B. Recent developments in the first detection of hepatocellular carcinoma. Clin Biochem Rev 26 (2005) 65-79
20. Vukotic V., Cerovic S., Kozomara M., and Lazic M. The predictive value of PSA in diagnosis of prostate cancer in non screened population. Acta Chir Iugosl 52 (2005) 81-87
21. Petricoin III E.F., Ornstein D.K., Paweletz C.P., Ardekani A., Hackett P.S., Hitt B.A., et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94 (2002) 1576-1578
22. Pawlik T.M., Hawke D.H., Liu Y., Krishnamurthy S., Fritsche H., Hunt K.K., et al. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 6 (2006) 68
23. Jr G.W., Cazares L.H., Leung S.M., Nasim S., Adam B.L., Yip T.T., et al. Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 2 (1999) 264-276
24. Melle C., Kaufmann R., Hommann M., Bleul A., Driesch D., Ernst G., et al. Proteomic profiling in microdissected hepatocellular carcinoma tissue using Protein chip technology. Int J Oncol 24 (2004) 885-891
25. Poon T.C., Chan K.C., Ng P.C., Chiu R.W., Ang I.L., Tong Y.K., et al. Serial analysis of plasma proteomic signatures in pediatric patients with severe acute respiratory syndrome and correlation with viral load. Clin Chem 50 (2004) 1452-1455
26. Poon T.C., Yip T.T., Chan A.T., Yip C., Yip V., Mok T.S., et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 49 (2003) 752-760
27. Traum A.Z., Wells M.P., Aivado M., Libermann T.A., Ramoni M.F., and Schachter A.D. SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions. Proteomics 6 (2006) 1676-1680
28. Gravett M.G., Novy M.J., Rosenfeld R.G., Reddy A.P., Jacob T., Turner M., et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 292 (2004) 462-469
29. Hundt S., Haug U., and Brenner H. Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 16 (2007) 1935-1953
30. Zheng G.X., Wang C.X., Qu X., Deng X.M., Deng B.P., and Zhang J. Establishment of serum protein pattern for screening colorectal cancer using SELDITOF-MS. Exp Oncol 28 (2006) 282-287
31. Chen Y.D., Zheng S., Yu J.K., and Hu X. Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 10 (2004) 8380-8385
32. Poon T.C., Sung J.J., Chow S.M., Ng E.K., Yu A.C., Chu E.S., et al. Diagnosis of gastric cancer by serum proteomic fingerprinting. Gastroenterology 130 (2006) 1858-1864
33. Su Y., Shen J., Qian H., Ma H., Ji J., Ma H., et al. Diagnosis of gastric cancer using decision tree classification of mass spectral data. Cancer Sci 98 (2007) 37-43
34. Liang Y., Fang M., Li J., Liu C.B., Rudd J.A., Kung H.F., et al. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Exp Mol Pathol 81 (2006) 176-180
35. Melle C., Ernst G., Scheibner O., Kaufmann R., Schimmel B., Bleul A., et al. Identification of specific protein markers in microdissected hepatocellular carcinoma. J Proteome Res 6 (2007) 306-315
36. Sun S., Lee N.P., Poon R.T., Fan S.T., He Q.Y., Lau G.K., et al. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. Liver Int 27 (2007) 1021-1038
37. Ward D.G., Cheng Y., N'Kontchou G., Thar T.T., Barget N., Wei W., et al. Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br J Cancer 94 (2006) 287-292
38. Au J.S., Cho W.C., Yip T.T., Yip C., Zhu H., Leung W.W., et al. Deep proteome profiling of sera from never-smoked lung cancer patients. Biomed Pharmacother 61 (2007) 570-577
39. Bouamrani A., Ternier J., Ratel D., Benabid A.L., Issartel J.P., Brambilla E., et al. Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin Chem 52 (2006) 2103-2106
40. Yang S.Y., Xiao X.Y., Zhang W.G., Zhang L.J., Zhang W., Zhou B., et al. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer 5 (2005) 83
41. Zhang Z., Bast Jr. R.C., Yu Y., Li J., Sokoll L.J., Rai A.J., et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 64 (2004) 5882-5890
42. Oh J.H., Nandi A., Gurnani P., Knowles L., Schorge J., Rosenblatt K.P., et al. Proteomic biomarker identification for diagnosis of early relapse in ovarian cancer. J Bioinform Comput Biol 4 (2006) 1159-1179
43. Wu S.P., Lin Y.W., Lai H.C., Chu T.Y., Kuo Y.L., and Liu H.S. SELDI-TOF MS profiling of plasma proteins in ovarian cancer. Taiwan J Obstet Gynecol 45 (2006) 26-32
44. Belluco C., Petricoin E.F., Mammano E., Facchiano F., Ross-Rucker S., Nitti D., et al. Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer. Ann Surg Oncol 14 (2007) 2470-2476
45. Gast M.C., Bonfrer J.M., Van Dulken E.J., De Kock L., Rutgers E.J., Schellens J.H., et al. SELDI-TOF MS serum protein profiles in breast cancer: assessment of robustness and validity. Cancer Biomark 2 (2006) 235-248
46. Noble J.L., Dua R.S., Coulton G.R., Isacke C.M., and Gui G.P. A comparative proteinomic analysis of nipple aspiration fluid from healthy women and women with breast cancer. Eur J Cancer 43 (2007) 2315-2320
47. Leong S., Christopherson R.I., and Baxter R.C. Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry. Cell Physiol Biochem 20 (2007) 579-590
48. Malik G., Rojahn E., Ward M.D., Gretzer M.B., Partin A.W., Semmes O.J., et al. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression. Prostate 67 (2007) 1565-1575
49. McLerran D., Grizzle W.E., Feng Z., Bigbee W.L., Banez L.L., Cazares L.H., et al. Analytical validation of serum proteomic profiling for diagnosis of prostate cancer; sources of sample bias. Clin Chem 54 (2008) 44-52
50. Pan Y.Z., Xiao X.Y., Zhao D., Zhang L., Ji G.Y., Li Y., et al. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer. Asian J Androl 8 (2006) 45-51